Company: IXHL
Filing Date: 2025-04-28
Form Type: 424B3
Source: 0001213900-25-036065
Chunk: 41

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-28
Form: 424B3
Chunk 41
---
 Nasdaq Stock Market LLC or any other stock exchange, market or trading facility on which the
Shares are traded or in private transactions. These sales may be at fixed or negotiated prices. A selling stockholder may use any one
or more of the following methods when selling Shares covered hereby:

| ● | ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; |

| ● | block trades in which the broker-dealer will attempt to sell the Shares as agent but may position and 
 resell a portion of the block as principal to facilitate the transaction;                             |

| ● | purchases by a broker-dealer as principal and resale by the broker-dealer for its account; |

| ● | an exchange distribution in accordance with the rules of the applicable exchange; |

| ● | privately negotiated transactions; |

| ● | settlement of short sales; |

| ● | in transactions through broker-dealers that agree with the selling stockholders to sell a specified number 
 of such Shares at a stipulated price per security;                                                         |

| ● | through the writing or settlement of options or other hedging transactions, whether through an options 
 exchange or otherwise;                                                                                 |

| ● | a combination of any such methods of sale; or |

| ● | any other method permitted pursuant to applicable law. |

The selling stockholders
may also sell the Shares under Rule 144 or any other exemption from registration under the Securities Act, if available, rather than under
this prospectus.

Broker-dealers engaged by
the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts
from the selling stockholders (or, if any broker-dealer acts as agent for the purchaser of Shares, from the purchaser) in amounts to be
negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a customary
brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance
with FINRA Rule 2121.

In connection with the sale
of the Shares or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the Shares in the course of hedging the positions they assume. The selling stockholders
may also sell the Shares short and deliver these Shares to close out their short positions, or loan or pledge the